sever
virus
associ
gastroenter
infant
pilot
studi
nest
within
larger
communitybas
project
earli
childhood
infect
collect
daili
symptom
data
weekli
stool
sampl
five
healthi
fulli
vaccin
term
infant
birth
second
birthday
realtim
pcr
assay
use
detect
six
enter
virus
frequent
silent
shed
one
six
virus
observ
particularli
involv
adenoviru
shed
could
month
without
gastrointestin
symptom
pilot
data
demonstr
posit
pcr
result
enter
virus
may
alway
indic
caus
childhood
gastroenter
acut
gastroenter
age
associ
virus
rotaviru
noroviru
adenoviru
major
contributor
global
childhood
mortal
morbid
liu
et
al
virus
rotaviru
main
caus
sever
diarrhea
young
children
account
childhood
death
worldwid
tate
et
al
recent
addit
oral
rotaviru
vaccin
onto
nation
immun
schedul
develop
countri
australia
follow
overal
decreas
childhood
diarrheal
ill
butteri
et
al
dey
et
al
countri
enter
viral
pathogen
especi
norovirus
lead
caus
sever
childhood
age
koo
et
al
recent
advanc
molecular
detect
method
help
reduc
diagnost
gap
children
age
amar
et
al
highli
sensit
techniqu
also
aid
discoveri
sever
new
enter
virus
includ
human
bocaviru
anelloviru
although
whether
novel
agent
genuin
pathogen
remain
controversi
kapusinszki
et
al
success
nation
rotaviru
vaccin
program
recent
discoveri
novel
virus
rais
import
question
rel
contribut
exist
emerg
enter
virus
childhood
diarrhea
far
studi
crosssect
lack
suitabl
control
base
healthcar
set
increas
likelihood
select
bia
scallan
et
al
lambert
et
al
aim
communitybas
pilot
studi
assess
preval
enter
viru
infect
associ
gastrointestin
symptom
first
year
life
five
otherwis
healthi
infant
recruit
prospect
birth
observ
research
childhood
infecti
diseas
orchid
project
communitybas
prospect
birth
cohort
studi
examin
natur
frequenc
acut
respiratori
gastrointestin
infect
infant
age
year
subtrop
citi
brisban
australia
parent
record
daili
diari
fever
respiratori
gastrointestin
symptom
infant
collect
nose
stool
swab
sampl
weekli
birth
infant
second
birthday
nose
stool
swab
sampl
submit
week
research
laboratori
regular
surfac
mail
order
inform
logist
plan
larger
studi
involv
infant
birth
cohort
conveni
sampl
first
five
orchid
particip
complet
studi
full
set
stool
sampl
includ
pilot
month
age
receiv
three
dose
oral
humanbovin
reassort
rotaviru
vaccin
rotateq
merck
inc
co
nj
part
queensland
public
fund
immun
program
actual
immun
date
confirm
australian
childhood
immunis
regist
human
research
ethic
committe
children
health
queensland
hospit
health
servic
royal
brisban
women
hospit
univers
queensland
approv
studi
six
enter
virus
test
use
polymeras
chain
reaction
pcr
revers
transcriptas
polymeras
chain
reaction
rtpcr
assay
choic
virus
determin
primarili
avail
pcr
templat
within
laboratori
includ
establish
enter
viru
pathogen
rotaviru
noroviru
recogn
emerg
respiratori
virus
associ
gastrointestin
symptom
adenovirussubgroup
f
human
coronaviru
human
system
virus
shed
gastrointestin
tract
enteroviru
nucleic
acid
extract
perform
describ
previous
ye
et
al
stool
sampl
homogen
approxim
ml
star
buffer
roch
diagnost
castl
hill
australia
make
stool
suspens
suspens
centrifug
remov
larg
particl
supernat
ml
underw
nucleic
acid
extract
extract
effici
inhibit
monitor
use
equin
herp
viru
spike
ye
et
al
pcr
realtim
pcr
rtpcr
test
specimen
dna
rna
virus
respect
perform
use
primer
probe
adenoviru
alsaleh
et
al
enteroviru
maunula
et
al
noroviru
group
ii
kageyama
et
al
rotaviru
pang
et
al
human
tozer
et
al
human
coronaviru
gunson
et
al
human
coronaviru
hku
dare
et
al
adenoviru
posit
sampl
character
use
establish
adenoviru
genotyp
method
saranti
et
al
adenovirusposit
sampl
reamplifi
pcr
use
primer
span
hypervari
region
hexon
gene
pcr
product
sent
autom
bidirect
sequenc
australian
genom
research
facil
sequenc
laboratori
univers
queensland
rotavirusposit
sampl
screen
vaccin
strain
rotateq
genespecif
quantit
rtpcr
assay
gautam
et
al
rotavirusposit
sampl
neg
rotateq
gene
genotyp
use
establish
method
base
rotaviru
g
p
sequenc
kirkwood
symptom
diari
captur
gastrointestin
symptom
daili
symptomat
episod
age
defin
loos
stool
andor
vomit
within
period
symptomat
episod
start
first
day
age
symptom
conclud
last
day
symptom
new
episod
requir
least
asymptomat
day
previou
episod
commenc
examin
whether
symptom
associ
higher
viral
load
linear
regress
model
construct
episod
type
symptomat
asymptomat
enter
main
effect
semiquantit
cycl
threshold
ct
valu
realtim
pcr
assay
outcom
analys
perform
stata
statacorp
colleg
station
tx
overal
stool
sampl
maximum
anticip
specimen
collect
five
infant
studi
period
median
interquartil
rang
time
specimen
reach
laboratori
day
collect
day
least
one
viru
detect
sampl
adenoviru
detect
frequent
n
follow
enteroviru
noroviru
human
rotaviru
human
coronaviru
singl
viru
detect
posit
sampl
two
codetect
sampl
three
three
sampl
frequent
codetect
adenoviru
enteroviru
n
codetect
follow
noroviru
either
adenoviru
n
enteroviru
n
adenoviru
posit
sampl
genotyp
success
observ
genotyp
adenoviru
serotyp
n
n
subgenu
serotyp
n
n
n
subgenu
c
serotyp
subgenu
f
n
failur
genotyp
remain
adenovirusposit
sampl
attribut
viral
load
detect
limit
genotyp
protocol
mean
ct
success
genotyp
detect
cycl
sd
cycl
sd
nongenotyp
detect
mean
differ
cycl
ci
six
seven
rotaviru
posit
sampl
observ
age
week
correspond
time
first
dose
rotateq
vaccin
remain
rotaviru
posit
sampl
collect
week
age
genotyp
show
five
rotaviru
posit
sampl
rotateq
vaccin
strain
sampl
week
wildtyp
strain
subject
remain
rotaviru
posit
sampl
subject
could
genotyp
due
low
viral
load
ct
valu
cycl
distribut
viru
detect
among
five
infant
summar
tabl
figur
age
episod
mark
virusposit
sampl
associ
gastrointestin
symptom
viru
detect
seven
episod
detect
viru
asymptomat
viru
detect
episod
among
individu
detect
virus
adenoviru
detect
serotyp
serotyp
serotyp
serotyp
nontyp
associ
symptom
similarli
enteroviru
noroviru
human
detect
accompani
symptom
howev
gastrointestin
symptom
associ
seven
rotaviru
posit
five
human
coronaviru
posit
sampl
symptomat
enteroviru
detect
lower
viral
load
asymptomat
detect
mean
ct
valu
differ
cycl
ci
tabl
similar
associ
observ
virus
contrast
unlik
four
particip
subject
symptomat
age
episod
rang
day
durat
none
six
virus
detect
variou
time
adenoviru
enteroviru
noroviru
period
continu
viru
shed
fig
last
long
week
adenoviru
week
enteroviru
week
noroviru
base
adenoviru
genotyp
data
adenoviru
serotyp
shed
continu
week
subject
week
subject
week
sequenti
detect
differ
viru
genotyp
also
observ
period
continu
adenoviru
shed
exampl
subject
infant
record
age
episod
first
year
life
serial
detect
adenoviru
type
occur
week
age
fig
pilot
studi
weekli
stool
sampl
five
children
communitybas
cohort
first
year
life
test
frequent
shed
one
target
six
virus
identifi
weekli
swab
often
absenc
gastrointestin
symptom
six
virus
noroviru
genogroup
ii
found
highest
proport
posit
detect
associ
gastrointestin
symptom
consist
rel
import
caus
age
young
children
alreadi
immun
rotaviru
infect
koo
et
al
find
confirm
extend
previou
observ
includ
two
infant
first
year
life
almost
constant
shed
variou
enter
virusesadenoviru
anelloviru
bocaviru
enteroviru
parechoviru
picobirnavirusin
weekli
stool
sampl
occasion
minor
symptom
present
kapusinszki
et
al
note
current
studi
durat
shed
observ
certain
adenoviru
type
adenovirusposit
sampl
could
assign
genotyp
due
low
viral
load
adenoviru
especi
adenoviru
type
could
shed
almost
month
without
gastrointestin
symptom
present
unlik
codetect
differ
adenoviru
genotyp
sequenti
detect
variou
adenoviru
type
observ
subject
period
receiv
littl
attent
literatur
two
three
genotyp
type
subgenu
c
subgenu
detect
intermitt
beforehand
subject
plausibl
serial
detect
report
infant
repres
independ
reactiv
two
genotyp
whose
genogroup
infect
lymphoid
tissu
differ
site
gastrointestin
tract
kosulin
et
al
follow
new
adenoviru
type
subgenu
c
infect
one
five
fulli
immun
children
wild
type
rotaviru
strain
detect
subclin
infect
identifi
week
age
remain
six
rotavirusposit
sampl
five
confirm
vaccin
strain
sixth
sampl
detect
first
dose
rotateq
vaccin
could
genotyp
next
sampl
subject
collect
later
confirm
rotateq
vaccin
strain
posit
data
support
find
recent
australian
studi
rotateq
vaccin
virus
account
rotaviru
pcr
posit
sampl
children
age
submit
stool
sampl
diagnost
test
schepetiuk
et
al
pilot
studi
also
identifi
issu
predict
valu
molecular
diagnost
assay
stool
sampl
infant
pcr
sensit
detect
stool
sampl
associ
gastrointestin
symptom
studi
suggest
limit
could
overcom
children
age
measur
viral
load
use
realtim
pcr
ct
valu
develop
cutoff
valu
detect
meaning
clinic
corcoran
et
al
howev
small
sampl
popul
ct
valu
enteroviru
detect
associ
significantli
symptom
given
enteroviru
recogn
minor
contributor
age
gastrointestin
symptom
like
part
system
ill
includ
fever
andor
rash
observ
differ
ct
valu
symptomat
asymptomat
viru
detect
rel
small
cycl
differ
viral
load
draw
conclus
data
must
done
caution
moreov
unlik
blood
defin
volumecel
number
quantifi
difficult
accur
assess
viral
load
stool
sampl
may
vari
wide
fluid
content
although
realtim
pcr
ct
valu
stool
sampl
use
surrog
semiquantit
estim
viral
load
still
limit
ct
valu
liquid
stool
may
underestim
viral
load
current
pilot
studi
involv
five
particip
recogn
viral
agent
associ
age
test
includ
astroviru
noroviru
group
virus
nevertheless
studi
assist
refin
method
workflow
much
larger
task
stool
test
entir
orchid
cohort
also
found
possibl
detect
multipl
virus
parentcollect
stool
specimen
return
laboratori
surfac
mail
addit
question
orchid
cohort
includ
detail
natur
durat
viru
shed
stool
healthi
infant
import
biolog
differ
exist
major
adenoviru
enteroviru
genotyp
shed
stool
includ
associ
gastrointestin
symptom
whether
ct
valu
cutoff
use
improv
diagnost
accuraci
viral
age
young
children
summari
data
highlight
complex
viral
shed
gastrointestin
tract
determin
diseasepathogen
associ
healthi
infant
young
children
result
affirm
extend
previou
observ
frequent
subclin
shed
multipl
divers
virus
stool
two
sibl
first
year
life
